Increased E‐cadherin expression has been shown to enhance sensitivity to chemotherapy, with mesenchymal‐like tumour cells exhibiting chemoresistance (Fuchs et al., 2008; Li et al., 2009; Witta et al., 2006; Yang et al., 2006). The gene discussed is CDH1; the disease is neoplasm.